↓ Skip to main content

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

Overview of attention for article published in Cancer Communications, October 2019
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
24 Mendeley